In multivariable linear regression analyses, use of bDMARDs (β −0.22, p = 0.03) at follow-up were associated with lower LV mass index at follow-up, independent of C-reactive protein (CRP), age, sex, and obesity at baseline. This evidence concerns the gene CRP and Obesity.